Verena Schoenau
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie S, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford C, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino M, Witte T, Neumann T, Holle J, Schoenau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos A, Voskuyl A, Daikeler T, Berger C, Molloy E, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel P, Cid M, González-Gay M, Morgan A, Martin-Broto J, Márquez A, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. Lancet Rheumatol 2024; 6:e374-e383.
08.05.2024Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
08.05.2024Lancet Rheumatol 2024; 6:e374-e383
Borrego-Yaniz Gonzalo, Ortiz-Fernández Lourdes, Madrid-Paredes Adela, Kerick Martin, Hernández-Rodríguez José, Mackie Sarah L, Vaglio Augusto, Castañeda Santos, Solans Roser, Mestre-Torres Jaume, Khalidi Nader, Langford Carol A, Ytterberg Steven, Beretta Lorenzo, Govoni Marcello, Emmi Giacomo, Cimmino Marco A, Witte Torsten, Neumann Thomas, Holle Julia U, Schoenau Verena, Pugnet Gregory, Papo Thomas, Haroche Julien, Mahr Alfred, Mouthon Luc, Molberg Øyvind, Diamantopoulos Andreas P, Voskuyl Alexandre, Daikeler Thomas D, Berger Christoph T, Molloy Eamonn S, Blockmans Daniel, van Sleen Yannick, Iles Mark, Sorensen Louise, Luqmani Raashid A, Reynolds Gary, Bukhari Marwan, Bhagat Shweta, Ortego-Centeno Norberto, Brouwer Elisabeth, Lamprecht Peter, Klapa Sebastian, Salvarani Carlo, Merkel Peter A, Cid María C, González-Gay Miguel A, Morgan Ann W, Martin-Broto Javier, Márquez Ana, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Rech J, Taşçilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber A, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler D, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester G, Karberg K, Strunk J, Cañete J, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino M, Østergaard M, Schett G. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet 2024; 403:850-859.
13.02.2024Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
13.02.2024Lancet 2024; 403:850-859
Rech Juergen, Taşçilar Koray, Hagen Melanie, Kleyer Arnd, Manger Bernhard, Schoenau Verena, Hueber Axel J, Kleinert Stefan, Baraliakos Xenofon, Braun Jürgen, Kiltz Uta, Fleck Martin, Rubbert-Roth Andrea, Kofler David M, Behrens Frank, Feuchtenberger Martin, Zaenker Michael, Voll Reinhard E, Venhoff Nils, Thiel Jens, Glaser Cornelia, Feist Eugen, Burmester Gerd R, Karberg Kirsten, Strunk Johannes, Cañete Juan D, Senolt Ladislav, Filkova Maria, Naredo Esperanza, Largo Raquel, Krönke Gerhard, D'Agostino Maria-Antonietta, Østergaard Mikkel, Schett Georg